This company has been marked as potentially delisted and may not be actively trading. Concert Pharmaceuticals (CNCE) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Concert Pharmaceuticals Short Interest DataConcert Pharmaceuticals (CNCE) has a short interest of 1.08 million shares. This marks a -58.46% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 2.97 million shares to cover all short positions.Current Short Interest1,080,000 sharesPrevious Short Interest2,600,000 sharesChange Vs. Previous Month-58.46%Dollar Volume Sold Short$9.02 millionShort Interest Ratio0.6 Days to CoverLast Record DateFebruary 15, 2023Outstanding Shares47,940,000 sharesPercentage of Shares Shorted2.25%Today's Trading Volume0 sharesAverage Trading Volume2,970,800 sharesToday's Volume Vs. Average0% Short Selling Concert Pharmaceuticals? Sign up to receive the latest short interest report for Concert Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCNCE Short Interest Over TimeCNCE Days to Cover Over TimeCNCE Percentage of Float Shorted Over Time Concert Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/15/20231,080,000 shares $9.02 million -58.5%N/A0.6 $8.35 1/31/20232,600,000 shares $21.68 million +19.8%N/A1.6 $8.34 1/15/20232,170,000 shares $15.30 million -0.9%N/A1.5 $7.05 12/30/20222,190,000 shares $12.79 million +10.1%N/A5 $5.84 12/15/20221,990,000 shares $9.37 million -4.3%N/A4.9 $4.71 11/30/20222,080,000 shares $10.03 million -5.0%N/A4.7 $4.82 11/15/20222,190,000 shares $10.86 million +3.3%N/A4.6 $4.96 10/31/20222,120,000 shares $12.61 million +12.8%N/A4.1 $5.95 10/15/20221,880,000 shares $11.41 million +13.3%N/A3.5 $6.07 9/30/20221,660,000 shares $11.12 million +33.9%N/A3.2 $6.70 Get the Latest News and Ratings for CNCE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Concert Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/15/20221,240,000 shares $8.32 million +15.9%N/A2.4 $6.71 8/31/20221,070,000 shares $7.04 million +24.0%N/A1.9 $6.58 8/15/2022863,200 shares $5.97 million -21.5%N/A0.9 $6.92 7/31/20221,100,000 shares $6.16 million No ChangeN/A1.2 $5.60 7/15/20221,100,000 shares $5.29 million +16.5%N/A1.3 $4.81 6/30/2022944,600 shares $3.98 million -10.9%N/A1.2 $4.21 6/15/20221,060,000 shares $4.74 million -19.7%N/A1.4 $4.47 5/31/20221,320,000 shares $8.40 million +777.7%N/A2.1 $6.36 5/15/2022150,400 shares $594.08 thousand +9.6%N/A0.9 $3.95 4/30/2022137,200 shares $429.44 thousand -14.7%N/A1.9 $3.13 4/15/2022160,800 shares $520.99 thousand -7.8%N/A2.2 $3.24 3/31/2022174,300 shares $587.39 thousand -3.7%N/A2.3 $3.37 3/15/2022180,900 shares $510.14 thousand -22.8%N/A1.9 $2.82 2/28/2022234,200 shares $702.60 thousand -9.1%N/A2 $3.00 2/15/2022257,600 shares $801.14 thousand -26.0%N/A2 $3.11 1/31/2022348,200 shares $1.06 million +10.2%N/A1.9 $3.03 1/15/2022316,100 shares $995.72 thousand -3.1%N/A0.4 $3.15 12/31/2021326,100 shares $1.03 million -51.6%N/A0.4 $3.15 12/15/2021674,000 shares $2.37 million -27.9%N/A0.8 $3.51 11/30/2021934,400 shares $3.16 million -16.6%N/A1.2 $3.38 11/15/20211,120,000 shares $4.49 million +118.9%N/A1.4 $4.01 10/29/2021511,600 shares $1.40 million -4.0%N/A0.7 $2.74 10/15/2021532,900 shares $1.53 million -4.1%1.7%6.3 $2.88 9/30/2021555,900 shares $1.82 million -15.2%1.8%6.2 $3.27 9/15/2021655,800 shares $2.26 million +5.6%2.1%3.6 $3.45 8/31/2021621,300 shares $2.35 million -3.6%2.0%2.9 $3.79 8/13/2021644,200 shares $2.15 million -10.8%2.1%2.8 $3.33 7/30/2021722,000 shares $2.40 million +2.2%2.4%2.9 $3.33 7/15/2021706,400 shares $2.53 million +15.3%2.4%2.5 $3.58 6/30/2021612,700 shares $2.59 million -54.6%2.1%2 $4.22Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. For the moment, you can watch this interview free of charge – just click here. 6/15/20211,350,000 shares $6.03 million -9.4%4.7%4.5 $4.47 5/28/20211,490,000 shares $5.99 million +5.7%5.1%5.1 $4.02 5/14/20211,410,000 shares $5.48 million +6.8%N/A4.5 $3.89 4/30/20211,320,000 shares $5.49 million +15.8%N/A3.6 $4.16 4/15/20211,140,000 shares $5.39 million +46.3%N/A2.2 $4.73 3/31/2021779,500 shares $3.79 million +15.8%N/A1.5 $4.86 3/15/2021672,900 shares $4.29 million -3.7%N/A1.5 $6.37 2/26/2021698,700 shares $4.80 million +19.4%N/A1.6 $6.87 2/12/2021585,100 shares $4.36 million -39.2%N/A1.4 $7.45 1/29/2021961,500 shares $10.44 million +14.0%N/A2.7 $10.86 1/15/2021843,200 shares $10.42 million +7.3%N/A4.8 $12.36 12/31/2020786,000 shares $9.96 million +13.2%N/A5 $12.67 12/15/2020694,200 shares $8.91 million -13.0%N/A4.4 $12.84 11/30/2020798,000 shares $9.07 million +3.8%N/A5.6 $11.37 11/15/2020769,000 shares $8.47 million +11.7%N/A5.9 $11.01 10/30/2020688,400 shares $7.39 million -4.5%N/A5.3 $10.74 10/15/2020721,000 shares $8.11 million +1.4%N/A5.6 $11.25 9/30/2020711,300 shares $6.98 million -4.7%N/A5.9 $9.82 9/15/2020746,400 shares $7.74 million -2.0%N/A6.1 $10.37 8/31/2020761,500 shares $7.33 million +2.2%N/A6.3 $9.62 8/14/2020744,900 shares $7.58 million -1.7%N/A5.9 $10.17 7/31/2020757,700 shares $7.02 million -2.7%N/A5.8 $9.27 7/15/2020778,500 shares $8.23 million +1.6%N/A5.6 $10.57 CNCE Short Interest - Frequently Asked Questions What is Concert Pharmaceuticals' current short interest? Short interest is the volume of Concert Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of February 15th, traders have sold 1,080,000 shares of CNCE short. Learn More on Concert Pharmaceuticals' current short interest. What is a good short interest ratio for Concert Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CNCE shares currently have a short interest ratio of 1.0. Learn More on Concert Pharmaceuticals's short interest ratio. Is Concert Pharmaceuticals' short interest increasing or decreasing? Concert Pharmaceuticals saw a decrease in short interest during the month of February. As of February 15th, there was short interest totaling 1,080,000 shares, a decrease of 58.5% from the previous total of 2,600,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Concert Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Concert Pharmaceuticals: Zymeworks Inc. (3.24%), Chimerix, Inc. (4.27%), Avid Bioservices, Inc. (18.17%), Revance Therapeutics, Inc. (4.32%), Checkpoint Therapeutics, Inc. (6.19%), Aerovate Therapeutics, Inc. (21.72%), 2seventy bio, Inc. (5.37%), Acelyrin, Inc. (4.87%), Procaps Group S.A. (0.12%), OptiNose, Inc. (1.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Enbridge Inc ($4.09 billion), Occidental Petroleum Corporation ($3.00 billion), T. Rowe Price Group, Inc. ($2.35 billion), Coinbase Global, Inc. ($2.30 billion), Paramount Global ($2.04 billion), Etsy, Inc. ($1.90 billion), Voya Financial, Inc. ($1.77 billion), CarMax, Inc. ($1.67 billion), Royal Caribbean Cruises Ltd. ($1.58 billion), and Monolithic Power Systems, Inc. ($1.47 billion). View all of the most shorted stocks. What does it mean to sell short Concert Pharmaceuticals stock? Short selling CNCE is an investing strategy that aims to generate trading profit from Concert Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Concert Pharmaceuticals? A short squeeze for Concert Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CNCE, which in turn drives the price of the stock up even further. How often is Concert Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNCE, twice per month. The most recent reporting period available is February, 15 2023. More Short Interest Resources from MarketBeat Related Companies Zymeworks Short Interest Chimerix Short Interest Avid Bioservices Short Interest Revance Therapeutics Short Interest Checkpoint Therapeutics Short Interest Aerovate Therapeutics Short Interest 2seventy bio Short Interest Acelyrin Short Interest Procaps Group Short Interest OptiNose Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNCE) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Concert Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Concert Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.